The global chronic kidney disease drugs market was valued at US$ 12,468.2 million in 2017 and is expected to witness a robust CAGR of 3.1% over the forecast period (2018 – 2026).
Chronic kidney disease (CKD) involves gradual loss of functioning of kidneys. The normal function of kidneys are to filter out and excrete wastes, and excess fluids from the blood are excreted through urine. However, when an individual is suffering from chronic kidney disease, kidneys cannot perform their natural function and wastes, fluids, and electrolytes build up in the body in excess amounts. Signs and symptoms of chronic kidney disease are not apparent until kidney function becomes significantly impaired. The supportive treatment of chronic kidney disease includes delaying the disease progression and kidney damage.
Request Sample Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/1713
Diseases and conditions such as type 1 or type 2 diabetes, high blood pressure, polycystic kidney disease, and recurrent kidney infection leads to chronic kidney disease. Factors that increase risk of chronic kidney disease include diabetes, high blood pressure, smoking, obesity, and others. Management of the disease involves managing the co-morbidities such as blood pressure, diabetes medications, medications to lower cholesterol levels, and anemia treatment. Kidney dialysis and kidney transplant may become a necessity, as the condition becomes worse. There is no direct medication available for the treatment of chronic kidney disease. Chronic kidney diseases may trigger other healthcare issues such as cardiovascular diseases.
Diseases such as diabetes and high blood pressure increase the risk of chronic kidney diseases. According to Kidney Health Australia, 2010, the cost of treating all current and new cases of End Stage Kidney Disease (ESKD) will reach up to US$ 12 billion by 2020. According to the Centers for Disease Control & Prevention (CDC), around 15% of the adults in the U.S. are estimated to have chronic kidney disease in 2017. CDC states that around 96% of the people with kidney damage or hampered kidney function are not aware of having chronic kidney disease, which indicates the underlying market potential in chronic kidney disease drugs market. Moreover, according to CDC, high blood pressure and diabetes are leading causes of chronic kidney disease. Approximately 1 in 3 adults with diabetes and 1 in 5 adults with high blood pressure might have chronic kidney disease.
Click To Continue Reading on Chronic Kidney Disease Drugs Market
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Email: [email protected]
You may be interested
Mycoplasma Diagnostics Market to Register Steady Expansion During 2018-2026Albert R - November 19, 2018
Mycoplasma Diagnostics Market research report 2018, is mostly driven by the improved taking on of Mycoplasma Diagnostics across small- and medium-sized enterprises. worldwide Mycoplasma Diagnostics Market quantifying…
Biopreservation Industry: Study Growth Factors, Types and Applications with Market Forecasts 2026Albert R - November 19, 2018
Biopreservation Market research report 2018, is mostly driven by the improved taking on of Biopreservation across small- and medium-sized enterprises. worldwide Biopreservation Market quantifying the talk on…
Dental Compressor Market – Global Industry – Key Players, Economic Impact, Cost and Revenue from 2018-2026Albert R - November 19, 2018
Dental Compressor Market research report 2018, is mostly driven by the improved taking on of Dental Compressor across small- and medium-sized enterprises. worldwide Dental Compressor Market quantifying…